Can you go home the same day after robotic hysterectomy? new study investigates
NCT ID NCT07233811
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches after robotic hysterectomy: going home the same day versus staying overnight in the hospital. Researchers will track quality of life and complications over 30 days in 300 patients with benign conditions or endometrial cancer. The goal is to see if same-day discharge is safe and helps patients recover faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that same-day discharge after robotic hysterectomy is safe and leads to faster recovery, potentially changing standard hospital practice.
- What could go wrong
- This is a relatively small, early-stage trial (300 participants) and results may not apply to all patients or hospitals. Complications or lower quality of life in the day-care group could limit adoption.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN UTERINE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Danderyd Hospital
RECRUITINGStockholm, Sweden
-
Karolinska University hospital
RECRUITINGStockholm, Sweden
-
Södersjukhuset
RECRUITINGStockholm, 11447, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple pressure test before surgery might reveal your risk of chronic pain
- Can a ketamine boost during surgery slash opioid needs?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?